The annual incidence of diagnosed venous thromboembolism (VTE) is 1 to 2 events per
1000 of the general population. VTE is very uncommon before age 20 years and, after 40 …

For many years, it has been well documented that combined hormonal contraceptives
increase the risk of venous thromboembolism (VTE). The third-generation pill use …

Background: Deep vein thrombosis (DVT) is a common postoperative complication that is
associated with significant morbidity and mortality. Thromboprophylaxis has been shown to …

Until recently, laboratory diagnosis of thrombophilia was based on investigation of the
plasmatic anticoagulant pathways to detect antithrombin, protein C, and protein S …

During their lifetimes, women face several unique situations with an increased risk of venous
thromboembolism (VTE). Doctors in a variety of specialties must advise women on the risks …

Risk of venous thrombosis with oral versus transdermal estro... : Current Opinion in Hematology
Risk of venous thrombosis with oral versus transdermal estrogen therapy among …

Objective.—To review the current state of the art regarding the role of the clinical laboratory
in diagnostic testing for the factor V Leiden (FVL) thrombophilic mutation (and other protein …

Objective—The purpose of this study was to investigate whether the effect of transdermal
estrogen therapy in postmenopausal women differs from that of oral therapy with regard to …

Importance Obesity is a risk factor for deep vein thrombosis of the leg and pulmonary
embolism. To date, however, whether obesity is associated with adult cerebral venous …

Thromboembolism is not uncommon in multiple myeloma (MM) patients on treatment, but its
pathogenesis remains poorly understood. We report the results of a prospective randomized …